Notably, IL-6, CCL2, GM-CSF, and KC/IL-8 have been identified as key biomarkers of ALI and ARDS, owing to their critical roles in the pathogenesis of pulmonary inflammation, endothelial and epithelial injury, and immune cell recruitment [3]. This evidence concerns the gene CSF2 and inflammatory response.